A Chalkbeat analysis identified about 175 Colorado centers currently owned or backed by private equity or venture capital ...

Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...

Trump opened the door for private equity to tap 401(k)s, and now private equity bosses want legal protection. Here's what ...

Wall Street is often blamed for reducing corporate managers’ understanding of business to a single, gameable measure of ...

Wall Street is still awaiting regulatory approval for the first full-blown private-asset ETFs, but for now opportunistic ...

Private-equity executives entered 2025 with high hopes for a dealmaking recovery that is lifting payouts to fund investors ...

That “waste-to-value” is increasingly getting quiet attention from private equity and infrastructure investors.

In 2024, global private equity and venture capital transaction value and volume in biotechnology declined to their lowest ...

Bluebird Bio will sell itself to private equity firms Carlyle and SK Capital for about $30 million, the company said Friday.

Andrea Auerbach, global head of private investments at Cambridge Associates, sizes up the industry’s prospects.

Private equity (PE) is the fastest-growing malignancy of the American healthcare system. In your new position as secretary of ...

ASIC is eyeing the future of investing and hellbent on keeping public and private markets on a level regulatory playing field ...